GNE-220

CAS No. 1199590-75-4

GNE-220( GNE220 )

Catalog No. M10715 CAS No. 1199590-75-4

GNE-220 is a potent and selective inhibitor of MAP4K4 with IC50 of 7 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1143 Get Quote
50MG 2322 Get Quote
100MG 3060 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GNE-220
  • Note
    Research use only, not for human use.
  • Brief Description
    GNE-220 is a potent and selective inhibitor of MAP4K4 with IC50 of 7 nM.
  • Description
    GNE-220 is a potent and selective inhibitor of MAP4K4 with IC50 of 7 nM, also inhibits MINK (MAP4K6), DMPK and KHS1 (MAP4K5) with IC50 of 9 nM, 476 nM and 1,110 nM; alters HUVEC sprout morphology, shifts the distribution of subcellular protrusion and increases total protrusions, dose-dependently increases the number of β1-integrin in long focal adhesions.
  • In Vitro
    GNE-220 also inhibits a few other kinases with IC50s of 9nM, 476 nM and 1.1μM for MINK (MAP4K6), DMPK and KHS1 (MAP4K5), respectively. GNE-220 alters human umbilical vein endothelial cells (HUVEC) sprout morphology. GNE-220 also reduces pERM+ retraction fibres in a dose-dependent manner. GNE-220 also dose-dependently increased the number of active-INTβ1+ long focal adhesions (FAs).
  • In Vivo
    ——
  • Synonyms
    GNE220
  • Pathway
    MAPK/ERK Signaling
  • Target
    MAP4K
  • Recptor
    MAP4K
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1199590-75-4
  • Formula Weight
    438.539
  • Molecular Formula
    C25H26N8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=C2C(=NC(=N1)C3=CN(N=C3)C)C4=C(N2)N=CC(=C4)C5=CC=C(C=C5)N6CCN(CC6)C
  • Chemical Name
    4-Methyl-8-[4-(4-methyl-1-piperazinyl)phenyl]-2-(1-methyl-1H-pyrazol-4-yl)-5H-pyrido[3',2':4,5]pyrrolo[3,2-d]pyrimidine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Vitorino P, et al. Nature. 2015 Mar 26;519(7544):425-30. 2. Gao X, et al. Cell Biosci. 2016 Oct 28;6:56. eCollection 2016.
molnova catalog
related products
  • MAP4K4-IN-11e

    A potent, selective, ATP-competitive inhibitor of MAP4K4 with IC50 of 1.9 uM.

  • PF 6260933 dihydroch...

    PF 6260933 is a potent, selective and orally bioavailable MAP4K4 inhibitor with kinase IC50 of 3.7 nM, cell IC50 of 160 nM.

  • HG6-64-1

    HG6-64-1 is a potent dual TAK1 and MAP4K2 ((germinal center kinase, GCK)) inhibitor with IC50 of 41 nM and 98 nM, respectively.